Brisbane, Australia

Jacky Yung Suen


 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacky Yung Suen: Innovator in Protease Activated Receptor Modulation

Introduction

Jacky Yung Suen is a prominent inventor based in Brisbane, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of protease activated receptors. With a total of 3 patents to his name, his work is paving the way for new therapeutic approaches to various diseases.

Latest Patents

Jacky Yung Suen's latest patents focus on novel compounds that serve as modulators of protease activated receptors. One of his inventions provides pharmaceutical compositions comprising these compounds, which can be utilized as tools for biological studies or as agents for therapies targeting metabolic syndrome, obesity, type II diabetes, fibrosis, and cardiovascular diseases. Another patent emphasizes the modulation of Protease Activated Receptor-2 (PAR2), offering potential treatments for individuals at risk of or suffering from disorders associated with undesirable PAR2 activity.

Career Highlights

Jacky is affiliated with The University of Queensland, where he conducts research and develops innovative solutions in the pharmaceutical field. His work is characterized by a commitment to advancing medical science and improving patient outcomes through targeted therapies.

Collaborations

Jacky has collaborated with notable colleagues, including David P Fairlie and Ligong Liu. These partnerships enhance the scope and impact of his research, contributing to the development of effective therapeutic strategies.

Conclusion

Jacky Yung Suen is a dedicated inventor whose work in protease activated receptor modulation holds promise for treating various health conditions. His innovative patents and collaborations reflect his commitment to advancing medical research and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…